CD8A and neoplasm: Collectively, these data indicate that low doses of DX, IRI, MTX, and OXP exert an immunomodulatory effect in the tumor immune microenvironment, facilitating both the recruitment of intratumoral DCs, CD8+ T cells and NK cells, and a partial control of tumor growth.